Minneapolis, MN, United States

University of Minnesota

www.umn.edu
Minneapolis, MN, United States

The University of Minnesota, Twin Cities is a public research university located in Minneapolis and St. Paul, Minnesota, United States. The Minneapolis and St. Paul campuses are approximately 5 miles apart, and the Saint Paul campus is actually in neighboring Falcon Heights. It is the oldest and largest campus within the University of Minnesota system and has the sixth-largest main campus student body in the United States, with 51,853 students in 2012–2013. The university is organized into 19 colleges and schools, and it has sister campuses in Crookston, Duluth, Morris, and Rochester.Minnesota's athletic teams are known collectively as the Minnesota Golden Gophers and compete in the NCAA's Division I as members of the Big Ten Conference. Wikipedia.


Time filter

Source Type

Patent
University of Minnesota | Date: 2017-03-01

The present invention provides compositions that include an extract of human feces, and methods for using such compositions, including methods for replacing or supplementing or modifying a subjects colon microbiota, and methods for treating a disease, pathological condition, and/or iatrogenic condition of the colon.


Patent
University of Minnesota | Date: 2017-02-06

Disclosed herein are isolated polypeptides, antibody preparations, treatment methods, diagnostic methods, and screening methods related to tauopathy. Generally, the isolated polypeptide includes a core pentapeptide, with the proviso that the isolated polypeptide is not a native full-length tau protein. Generally, the antibody preparations include antibody that specifically binds to SEQ ID NO:12. Generally, the treatment methods include administering to a subject a composition that includes the isolated polypeptide. Generally, the diagnostic methods includes contacting a sample from a subject with an antibody preparation that includes antibody that specifically binds to SEQ ID NO:12, and then detecting a ligand in the sample that specifically binds the antibody preparation. Generally, the screening method includes incubating a mixture of caspase-2, a labeled caspase-2 cleavage substrate, and a test compound under conditions effective to permit the caspase-2 to cleave the caspase-2 cleavage substrate, then determining whether the test compound inhibits cleavage of the substrate by caspase-2.


Patent
Ecolab and University of Minnesota | Date: 2017-04-26

The present disclosure provides for a composition and method for attracting bed bugs to a trap or to a location where an insecticide or pesticide is present, or to a trap or a location where a bed bug infestation can be detected. The present disclosure provides for a composition for attracting bed bugs that includes one or more of methyl diethanolamine (MDEA), monoethanolamine (MEA), diethanolamine (DEA), triethanolamine (TEA), and dimethyl trisulfide (DMTS); a carrier; and optionally one or more amides selected from oleamide, octanamide, nonanamide, and laurylamide; urea, biuret, or triuret; and one or more aliphatic fatty acids. The present disclosure further provides for a method for treating an article by applying the composition to the article, where the article comprises a device for trapping or detecting bed bugs or a device for treating a bed bug infestation.


Patent
University of Minnesota | Date: 2017-03-13

Methods and materials useful for applying pharmacologic agents to the ear are described. The methods involve delivering a composition that contains at least one viscogenic agent and at least one pharmacologic agent to the epidermal surface of the tympanic membrane via the ear canal. The composition is delivered to the tympanic membrane in a flowable form and, after delivery to the tympanic membrane, becomes sufficiently viscous such that the pharmacologic agent is localized against the tympanic membrane. Such compositions can be used to prophylactically and/or therapeutically treat middle and inner ear conditions, including otitis media.


Patent
University of Minnesota | Date: 2017-02-22

Block copolymers include a poly -methyl--valerolactone (PMVL) block. The PMVL blocks can be formed from biosynthesized -methyl--valero lactone (MVL). The block copolymers can include hard blocks. The block copolymers can be thermoplastic elastomers.


Patent
Sangamo Therapeutics Inc. and University of Minnesota | Date: 2017-01-12

Nucleases and methods of using these nucleases for inserting a sequence encoding a therapeutic IDUA or IDS protein such as an enzyme into a cell, thereby providing proteins or cell therapeutics for treatment and/or prevention of MPS I or MPS II disease.


Patent
University of Minnesota | Date: 2017-02-08

Disclosed herein are techniques for graphically indicating aspects of rotors (such as pivot points of rotors) associated with atrial or ventricular fibrillation. Embodiments can include receiving, using a processor, an electrogram for each of a plurality of spatial locations in a heart, each electrogram comprising time series data including a plurality of electrical potential readings over time. Embodiments can also include generating, from the time series data, one or more of multi-scale frequency (MSF), kurtosis, empirical mode decomposition (EMD), and multi-scale entropy (MSE) datasets, each dataset including a plurality of respective values or levels corresponding to the plurality of spatial locations in the heart. Also, examples can include generating, from the one or more datasets, a map including a plurality of graphical indications of the values or levels at the plurality of spatial locations in the heart, wherein the map can include an image of the heart and graphical indications of locations of aspects of rotors in the heart (such as pivot point of rotors).


Patent
University of Minnesota | Date: 2017-01-27

The invention provides compounds of formula I: wherein R_(1)R_(3), R^(a), and R^(b )have any of the values defined herein, and salts thereof. The compounds have immunomodulatory properties.


Patent
University of Minnesota | Date: 2017-02-01

A method of extracting particles from a two-dimensional (2D) hologram recorded as part of a digital inline holography system includes reconstructing a three-dimensional (3D) optical field from the recorded 2D hologram. In addition, particles are extracted/segmented from the 3D optical field, wherein segmented particles are identified by particle location in three-dimensional space and a cross-sectional area of the segmented particle. Based on the identified particle location and cross-sectional area, extracted particles are removed from the 2D hologram to generate an updated 2D hologram. These steps are repeated iteratively until a threshold is met.


Patent
University of Minnesota | Date: 2017-08-02

Provided herein are genetically engineered Pichinde viruses that include three ambisense genomic segments. The first genomic segment includes a coding region encoding a Z protein and a coding region encoding a L RdRp protein. The second genomic segment includes a coding region encoding a nucleoprotein (NP) and the third genomic segment includes a coding region encoding a glycoprotein. Each of the second and third genomic segments optionally include an additional coding region that may encode an antigen or a detectable marker. Also provided herein is a reverse genetics system for making a genetically engineered Pichinde virus, and a collection of vectors that can be used to produce a genetically engineered Pichinde virus. Further provided are methods for using a reverse genetics system, and methods for producing an immune response in a subject.

Loading University of Minnesota collaborators
Loading University of Minnesota collaborators